Ketamine subcutaneous continuous infusion for non-cancer neuropathic pain at home: a case report

BMJ supportive & palliative care(2023)

引用 0|浏览4
暂无评分
摘要
Objective Ketamine is a drug that can effectively treat neuropathic pain by blocking the N-methyl-D-aspartate receptor. It has been studied as a supplement to opioids for cancer pain, but its effectiveness for non-cancer pain is still limited. However, despite its usefulness in managing refractory pain, ketamine is not commonly used for home-based palliative care. Methods A case report of a patient with severe central neuropathic pain who was treated with a subcutaneous continuous infusion of morphine and ketamine at home. Results The introduction of ketamine in the patient’s treatment plan effectively controlled pain. Only one possible ketamine side effect was observed and easily treated with pharmacological and non-pharmacological measures. Conclusions We have found success in using subcutaneous continuous infusion of morphine and ketamine to alleviate severe neuropathic pain in a home setting. We also observed a positive impact on the patient’s family members' personal, emotional and relational well-being after ketamine was introduced.
更多
查看译文
关键词
ketamine subcutaneous continuous infusion,pain,non-cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要